Vertex Pharmaceuticals Inc (VRTX): Depreciation & Amortization
$209.80M
Year ended 2025-12-31
$222.10M
Trailing 12 months to 2026-06-30
+12.3%
3-year compound annual growth
+13.9%
5-year compound annual growth
+12.9%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $209.80M | +1.3% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $207.20M | +14.3% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $181.30M | +22.3% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $148.30M | +18.1% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $125.60M | +14.7% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $109.50M | +2.4% | 2023-02-10, From 2020-01-01 |
| 2019-12-31 | $106.90M | +47.6% | 2022-02-09, From 2019-01-01 |
| 2018-12-31 | $72.42M | +18.0% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $61.40M | 0.0% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $61.40M | -1.5% | 2019-02-13, From 2016-01-01 |
| 2015-12-31 | $62.34M | -1.4% | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | $63.26M | +30.8% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $48.37M | +26.6% | 2016-02-16, From 2013-01-01 |
| 2012-12-31 | $38.19M | +9.0% | 2015-02-13, From 2012-01-01 |
| 2011-12-31 | $35.04M | +15.0% | 2014-02-11, From 2011-01-01 |
| 2010-12-31 | $30.46M | +1.2% | 2013-03-01, From 2010-01-01 |
| 2009-12-31 | $30.11M | -6.5% | 2012-02-22, From 2009-01-01 |
| 2008-12-31 | $32.20M | n/a | 2011-02-17, From 2008-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $209.80M | +1.3% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $1.21B | -4.7% |
| Viatris Inc (VTRS) | 2025-12-31 | $2.80B | -3.3% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $543.70M | +12.6% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $487.00M | -2.0% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $1.00B | -5.4% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $141.69M | -17.5% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $680.00M | +2.7% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $41.60M | +26.8% |
Compare VRTX, BHC, VTRS, REGN side by side · Screen every company in Pharmaceutical Preparations ↗